Collins KA - Search Results

1

Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.

Costi S, Morris LS, Kirkwood KA, Hoch M, Corniquel M, Vo-Le B, Iqbal T, Chadha N, Pizzagalli DA, Whitton A, Bevilacqua L, Jha MK, Ursu S, Swann AC, Collins KA, Salas R, Bagiella E, Parides MK, Stern ER, Iosifescu DV, Han MH, Mathew SJ, Murrough JW. Costi S, et al. Among authors: collins ka. Am J Psychiatry. 2021 May 1;178(5):437-446. doi: 10.1176/appi.ajp.2020.20050653. Epub 2021 Mar 3. Am J Psychiatry. 2021. PMID: 33653118 Free PMC article. Clinical Trial.

2

Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.

Price RB, Shungu DC, Mao X, Nestadt P, Kelly C, Collins KA, Murrough JW, Charney DS, Mathew SJ. Price RB, et al. Among authors: collins ka. Biol Psychiatry. 2009 May 1;65(9):792-800. doi: 10.1016/j.biopsych.2008.10.025. Epub 2008 Dec 5. Biol Psychiatry. 2009. PMID: 19058788 Free PMC article.

3

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.

Mathew SJ, Murrough JW, aan het Rot M, Collins KA, Reich DL, Charney DS. Mathew SJ, et al. Among authors: collins ka. Int J Neuropsychopharmacol. 2010 Feb;13(1):71-82. doi: 10.1017/S1461145709000169. Epub 2009 Mar 17. Int J Neuropsychopharmacol. 2010. PMID: 19288975 Free PMC article. Clinical Trial.

4

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, Mathew SJ. aan het Rot M, et al. Among authors: collins ka. Biol Psychiatry. 2010 Jan 15;67(2):139-45. doi: 10.1016/j.biopsych.2009.08.038. Biol Psychiatry. 2010. PMID: 19897179 Clinical Trial.

5

Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder.

Murrough JW, Mao X, Collins KA, Kelly C, Andrade G, Nestadt P, Levine SM, Mathew SJ, Shungu DC. Murrough JW, et al. Among authors: collins ka. NMR Biomed. 2010 Jul;23(6):643-50. doi: 10.1002/nbm.1512. NMR Biomed. 2010. PMID: 20661876

6

Tryptophan depletion and emotional processing in healthy volunteers at high risk for depression.

Feder A, Skipper J, Blair JR, Buchholz K, Mathew SJ, Schwarz M, Doucette JT, Alonso A, Collins KA, Neumeister A, Charney DS. Feder A, et al. Among authors: collins ka. Biol Psychiatry. 2011 Apr 15;69(8):804-7. doi: 10.1016/j.biopsych.2010.12.033. Epub 2011 Mar 5. Biol Psychiatry. 2011. PMID: 21377656 Free PMC article. Clinical Trial.

7

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV. Murrough JW, et al. Among authors: collins ka. Biol Psychiatry. 2013 Aug 15;74(4):250-6. doi: 10.1016/j.biopsych.2012.06.022. Epub 2012 Jul 27. Biol Psychiatry. 2013. PMID: 22840761 Free PMC article. Clinical Trial.

8

Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response.

Murrough JW, Wan LB, Iacoviello B, Collins KA, Solon C, Glicksberg B, Perez AM, Mathew SJ, Charney DS, Iosifescu DV, Burdick KE. Murrough JW, et al. Among authors: collins ka. Psychopharmacology (Berl). 2013 Sep 11:10.1007/s00213-013-3255-x. doi: 10.1007/s00213-013-3255-x. Online ahead of print. Psychopharmacology (Berl). 2013. PMID: 24022236 Free PMC article.

9

Cognitive-emotional training as an intervention for major depressive disorder.

Iacoviello BM, Wu G, Alvarez E, Huryk K, Collins KA, Murrough JW, Iosifescu DV, Charney DS. Iacoviello BM, et al. Among authors: collins ka. Depress Anxiety. 2014 Aug;31(8):699-706. doi: 10.1002/da.22266. Epub 2014 Apr 17. Depress Anxiety. 2014. PMID: 24753225 Clinical Trial.

10

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder.

Murrough JW, Collins KA, Fields J, DeWilde KE, Phillips ML, Mathew SJ, Wong E, Tang CY, Charney DS, Iosifescu DV. Murrough JW, et al. Among authors: collins ka. Transl Psychiatry. 2015 Feb 17;5(2):e509. doi: 10.1038/tp.2015.10. Transl Psychiatry. 2015. PMID: 25689570 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

287 results

Search Page